Información adicional

• Num_publicacion 76(9-10)
• Resumen_ingles
  Cow’s milk protein allergy (CMPA) is the most frequent food allergy in infants and young children with a prevalence of 2-3%. The recommendations for the treatment of the CMPA are based on the guidelines of medical societies such as Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) of the World Allergy Organization, Nutrition Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the Food Allergy Committee of the Spanish Society of Pediatric Allergy, Asthma and Clinical Immunology (SEICAP), are based on 3 basic points: Strict avoidance of the milk protein, maintenance of optimal nutritional status and acquisition of tolerance as soon as possible.
  Substitute formulas, when breastfeeding is not possible, to nourish children affected by CMPA are the so-called hypoallergenic formulas that are: formulas based on extensively hydrolyzed cow’s milk proteins (with/without lactose), formulas based on hydrolyzed rice proteins, soy formulas (isolated or hydrolyzed) and elemental formulas based on free L-amino acids.
  Knowing the composition of each of these formulas is important to decide what type of food is indicated in each case.
   
• Palabras_clave_ingles Cow’s milk protein allergy Hypoallergenic formulas Degree of hydrolysis hypoallergenic formulas
• Todos_autores B. Martín Martínez
• autores listados B. Martín Martínez
• Correspondecia
  B. Martín Martínez. Unidad de Gastroenterología y Nutrición Infantil. Servicio de Pediatría. Hospital de Terrassa.  Ctra. Torrebonica, s/n. 08227 Terrassa (Barcelona).
  Correo electrónico: bmartingastro@hotmail.com
• Titulo_ingles Extensively hydrolyzed formulas. Role of the protein hydrolysis degree
• Centros_trabajo Unidad de Gastroenterología y Nutrición Infantil. Servicio de Pediatría. Hospital de Terrassa (Barcelona)
• Publicado en Acta Pediatr Esp. 2018; 76(9-10): 115-122
• copyright ©2018 Ediciones Mayo, S.A.
• Fecha recepcion 13/09/18
• Fecha aceptacion 15/09/18
• Tipo de Artículo Clínico (Microdatos) Review